T1	Participants 194 232	patients with atrial fibrillation (AF)
T2	Participants 651 756	multinational (44 countries) trial of patients with nonvalvular AF and at least 1 risk factor for stroke.
T3	Participants 795 811	18,113 patients.
T4	Participants 812 893	Patients who were VKA-naive and experienced are included in balanced proportions.
